ResearchMoz

Humalog (Type 2 Diabetes) - Analysis and Forecasts to 2020

GlobalData
Published Date » 2012-01-31
No. Of Pages » 44


GlobalDatas pharmaceuticals report, Humalog (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Humalog sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Type 2 Diabetes market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Scope

  • Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
  • Analysis and review of Humalog including historical sales data
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Humalog including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Detailed sales forecast for 2011-2020 for Humalog in each of the seven major markets
Reasons to buy

  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance 
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Introduction 5
2.1 Diabetes 5
2.2 Epidemiology 5
2.2.1 Prevalence 5
2.2.2 Mortality 7
2.3 Etiology and Risk Factors 9
2.3.1 Obesity 9
2.3.2 Sedentary Lifestyle 9
2.3.3 Family History and Genetics 9
2.3.4 Ethnicity 9
2.3.5 Old Age 9
2.4 Economic Impact of Diabetes 9
2.5 GlobalData Report Guidance 11

3 Type 2 Diabetes: Market Characterization 12
3.1 Type 2 Diabetes Market 12
3.2 Type 2 Diabetes Market Forecasts 13
3.3 Type 2 Diabetes Market: Drivers and Restraints 14
3.3.1 Drivers 14
3.3.2 Restraints 15

4 Classification of Diabetes 16
4.1 Types of Diabetes 16
4.1.1 Type 1 Diabetes 16
4.1.2 Type 2 Diabetes 16
4.1.3 Gestational Diabetes 16
4.2 Diabetes Complications 16
4.2.1 Cardiovascular Disease 16
4.2.2 Nephropathy 17
4.2.3 Neuropathy 17
4.2.4 Amputation 17
4.2.5 Retinopathy 17
5 Evolution of Anti-Diabetic Treatments 18

6 Medications 20
6.1 Insulin 20
6.2 Oral Medications 20
6.2.1 Sulfonylureas (SUR) 20
6.2.2 Biguanides (BGDs) 20
6.2.3 Alpha-Glucosidase Inhibitors (AGI) 22
6.2.4 Meglitinides 22
6.2.5 Thiazolidinediones (TZDs) 23
6.2.6 Dipeptidyl Peptidase IV (DPP- 4) Inhibitors 24
6.2.7 Oral Combination Therapy 24
6.3 Other Injectionable Medications 25
6.3.1 Pramlintide 25
6.3.2 Exenatide 25
6.4 Market Share as per Classes in Type 2 Diabetes 25

7 Humalog (insulin lispro) 26
7.1 Introduction 26
7.2 Mechanism of Action 26
7.3 Clinical Studies 26
7.3.1 Safety & Efficacy Study in Humalog & Humulin R 26
7.3.2 Comparison of Means of Glycemic Parameters 27
7.3.3 Combination Therapy 27
7.4 Approval History of Humalog 28
7.5 Factors Affecting Sales of Humalog 28
7.5.1 Growing Insulin Market 28
7.5.2 First in Class 28
7.5.3 Advantage of Humalog over Regular Insulin 28
7.5.4 Prevention of Spiking Blood Sugar between Meals 28
7.5.5 Effective Treatment for Low Blood Sugar at Night 28
7.6 Drug Evaluation 29
7.6.1 Drug Risk Benefit Score 29
7.6.2 Intensity of Competition 30
7.7 Sales Estimates 30
7.7.1 Target Patient Pool for Humalog 30
7.7.2 Dosing 30
7.7.3 Market Penetration 31
7.7.4 Annual Cost of Therapy 31
7.7.5 Sales Projections of Humalog 32

8 Diabetes Market: Appendix 41
8.1 Market Definitions 41
8.2 List of Abberiviations 41
8.3 Research Methodology 41
8.3.1 Coverage 42
8.3.2 Secondary Research 42
8.3.3 Forecasting 42
8.3.4 Number of patients approved to take the drug 42
8.3.5 Net Penetration of Drug 43
8.3.6 Net Annual Dosing 43
8.3.7 Annual Cost of Therapy 43
8.4 Drug Sales Estimates Model 43
8.5 Contact Us 43
8.6 Disclaimer 44
8.7 Sources 44

List of Tables


Table 1: Diabetes, World, Prevalence Estimates for the age group 20-79 years (million), 2000-2030 5
Table 2: Diabetes, Top 10 Countries, by Prevalence (million), 2010 and 2030 7
Table 3: Diabetes, Top 10 Countries, Highest Health Expenditures ($bn), 2010 10
Table 4: Type 2 Diabetes, World, Major Marketed Drugs By Sales ($m), 2010 12
Table 5: Type 2 Diabetes, World, Major Pipeline Products in Phase III 13
Table 6: Diabetes, Worldwide, Prevalence Estimates, 2010 and 2030 14
Table 7: Overweight*, Global, Prevalence Estimates in Males Aged 15 and above (%), 2005 15
Table 8: Diabetes Drugs Evolution 19
Table 9: Type 2 Diabetes Mellitus Adults 26
Table 10: Comparison of Means of Glycemic Parameters at the end of Combined Treatment periods (3 months for each treatment) 27
Table 11: Results of a Two Month Study in which Humalog was added to Sulfonylurea therapy in Patients not adequately controlled on Sulfonylureas alone 27
Table 12: Approval of Humalog 28
Table 13: Drug Risk Benefit Score, Humalog 29
Table 14: Drug Risk Benefit Score, Humalog Mix 75/25 29
Table 15: Humalog, Annual Cost of Therapy in Type 2 Diabetes, Global, 2011 31
Table 16: Humalog Mix 75/25, Annual Cost of Therapy in Type 2 Diabetes, Global, 2011 31
Table 17: Humalog franchise, Annual Cost of Therapy in Type 2 Diabetes, Global, 2011 31
Table 18: Humalog, Type 2 Diabetes, Global, Sales Estimates ($m), 20022020 32
Table 19: Humalog, Type 2 Diabetes, The US, Sales Estimates ($m), 20022020 33
Table 20: Humalog, Type 2 Diabetes, The UK, Sales Estimates ($m), 20022020 34
Table 21: Humalog, Type 2 Diabetes, France, Sales Estimates ($m), 20022020 35
Table 22: Humalog, Type 2 Diabetes, Germany, Sales Estimates ($m), 20022020 36
Table 23: Humalog, Type 2 Diabetes, Italy, Sales Estimates ($m), 20022020 37
Table 24: Humalog, Type 2 Diabetes, Spain, Sales Estimates ($m), 20022020 38
Table 25: Humalog, Type 2 Diabetes, Japan, Sales Estimates ($m), 20022020 39

List of Figures


Figure 1: Diabetes, World, Comparative Prevalence in Age Group 20-79 years (%), 2010 6
Figure 2: Diabetes, World, Comparative Prevalence in Age Group 20-79 years (%), 2030 6
Figure 3: Diabetes, World, Mortality, 2010 7
Figure 4: Top 10 Causes of Mortality, Worldwide, 2008 8
Figure 5: Type 2 Diabetes, Global, Market Size Forecasts ($bn), 20102020 13
Figure 6: Mechanism of Action of Sulfonylureas 20
Figure 7: Mechanism of Action of Biguanide, Thiazolidinediones, Alpha-Glucosidase Inhibitors 21
Figure 8: Mechanism of Action of Metformin and Alpha-Glucosidase Inhibitors 22
Figure 9: Mechanism of Action of Thiazolidinediones 23
Figure 10: Mechanism of Action of DPP IV Inhibitors 24
Figure 11: Type 2 Diabetes, Global, Market Share by Value, By Class (%), 2010 25
Figure 12: Humalog, Type 2 Diabetes, Global, Sales Estimates ($m), 2002-2020 32
Figure 13: Humalog, Type 2 Diabetes, The US, Sales Estimates ($m), 20022020 33
Figure 14: Humalog, Type 2 Diabetes, The UK, Sales Estimates ($m), 20022020 34
Figure 15: Humalog, Type 2 Diabetes, France, Sales Estimates ($m), 20022020 35
Figure 16: Humalog, Type 2 Diabetes, Germany, Sales Estimates ($m), 20022020 36
Figure 17: Humalog, Type 2 Diabetes, Italy, Sales Estimates ($m), 20022020 37
Figure 18: Humalog, Type 2 Diabetes, Spain, Sales Estimates ($m), 20022020 38
Figure 19: Humalog, Type 2 Diabetes, Japan, Sales Estimates ($m), 2002-2020 39
Figure 20: Humalog, Type 2 Diabetes, Sales Distribution by Country (%), 2020 40
Figure 21: Patients Approved for the Drug 43

Upcoming Reports:

Gas Detector Equipment Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Gas detector is a device which detects the gases present within an area. Gas detectors are designed to provide protection against hazardous atmospheres.  It is usually a part of safety system which is used to detect gas leak occurring. A gas detector has a fire alarm which operates in the area where the leakage is occurring and gives an opportunity to leave the area. This type of device helps to prevent from various harmful gases. The gas detector equipment market is expected to see a growth as one of the main factors is contributing towards market growth is government...
Home Medical Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The global home medical equipment consumption pattern will depend on demographic and epidemiological development. Increased efforts in the fight against chronic illnesses such as respiratory diseases, kidney disorders, and cancer will boost the demand for home therapeutic devices. Products such as portable oxygen concentrators, continuous positive airway products, ventilators, and other accessories will undergo the fastest growth in sales in this market. Increasing numbers of baby boomers and an increase in the population of aged people on a global scale will also assist in the growth...
Microcrystalline Cellulose Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Microcrystalline cellulose is refined and partially de-polymerized wood pulp and is commonly found in the form of a white, freely flowing powder. Microcrystalline cellulose is inert in nature and chemically non-reactive with body fluids. It does not degrade during digestion and has a low absorption quotient. Microcrystalline cellulose is majorly used in foodstuffs to impart dietary bulk and can also be used as a natural laxative. It is prepared by treating alpha-cellulose and is obtained in the form of pulp from fibrous plant material. Microcrystalline cellulose finds...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

World Cup Stadium at Qatar to be Renovated for 2022 FIFA World Cup
Nov 26, 2014  
The design for renovation of the Khalifa International Stadium will soon be unveiled by the organization that is responsible for building the infrastructure and stadiums for the 2022 FIFA World Cup Qatar. The main construction work on the stadium is being looked into by two prominent construction companies. The joint venture is between Six Construct and Midmac Contracting. Six Construct is a...
DOD Spending Low, Corps Look for More Work in Alaska
Nov 24, 2014  
Military construction across Alaska continues to decline. Government contractors expect to keep busy for the time being with work delegated by other federal agencies. The United States Army Corps of Engineers expects to have more than US$410 million worth of work available on at least 400 projects in the 2015 fiscal year. Chris Tew, the Alaska Contracting Division chief said that is...
China Consumer Products Fair Kicks-Off in Abu Dhabi
Nov 24, 2014  
Seeking to market products in the United Arab Emirates (UAE) and Mena regions, more than 100 consumer goods makers from China showcased their mid-to-high-end consumer goods at the China Consumer Products Fair. The second edition of the China Consumer Products Fair 2014 began on Monday in Abu Dhabi’s National Exhibition Center (Adnec). The event was officially inaugurated by the Economic...
Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...